The Lancet research papers build on the WHO’s Guidance for best practices in clinical trials released in September 2024.

FDA has cleared an investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001 + SWI019) in patients with autoimmune conditions. Patient ...

"An appealing feature of [intermittent fasting] is that dieters do not have to focus on counting calories and restricting ...

There are a number of reasons why patients with cancer are encouraged to enroll in clinical trials, Dr. Michael J. Pishvaian ...

The global US Clinical Trial Services Market is expected to reach US$39.61 billion by 2030 from US$25.57 billion in 2025, at ...